VANCOUVER, British Columbia, Aug. 25, 2023 (GLOBE NEWSWIRE) — MindBio Therapeutics (CSE:MBIO) (FSE:WF6), an Australia-based... The post InvestmentPitch...
The psychedelic industry is changing and growing rapidly. Psychedelic medicines are being catapulted into the mainstream, and these top 10 psychedelic...
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing...
The brain health brand took in its first institutional capital with plans to go into over 1,800 retail stores in the next year.
Atai Life Sciences Q2 financial results were released recently, alongside an update on the company’s pipeline progression. So, we figured it would be...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Psychedelics are creating an alternative form of healthcare, so it is only reasonable that the industry would seek out alternative sources of funding....
On Monday, Cybin released the financial results for its first quarter, ending June 30, 2023. As of June 30, 2023, the company had $9.4 million (Canadian...
If all warrants are exercised, an additional $160 million comes into play. The post Compass Pathways Lands $125M Investment appeared first on Green Market...
COMPASS Pathways has announced a capital raise of up to $285 million, the largest cash injection the industry has seen in quite some time. The post COMPASS...